000 01699 a2200517 4500
005 20250516215548.0
264 0 _c20150724
008 201507s 0 0 eng d
022 _a1559-131X
024 7 _a10.1007/s12032-014-0048-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZeng, Yue-Can
245 0 0 _aSerum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy.
_h[electronic resource]
260 _bMedical oncology (Northwood, London, England)
_cJul 2014
300 _a48 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBrain Neoplasms
_xmortality
650 0 4 _aCA-125 Antigen
_xblood
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xblood
650 0 4 _aMale
650 0 4 _aMembrane Proteins
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aMultivariate Analysis
650 0 4 _aPrognosis
650 0 4 _aSurvival Rate
650 0 4 _aTumor Burden
700 1 _aWu, Rong
700 1 _aWang, Si-Liang
700 1 _aChi, Feng
700 1 _aXing, Rui
700 1 _aCai, Wei-Song
700 1 _aFan, Guo-Liang
700 1 _aFan, Yu-Chen
700 1 _aZhong, Wen-Zhao
700 1 _aWu, Li-Na
700 1 _aChen, Xiao-Dong
700 1 _aChen, Huan-Huan
700 1 _aXiao, Yu-Ping
773 0 _tMedical oncology (Northwood, London, England)
_gvol. 31
_gno. 7
_gp. 48
856 4 0 _uhttps://doi.org/10.1007/s12032-014-0048-y
_zAvailable from publisher's website
999 _c23904121
_d23904121